PD-L1 is classically characterized as membrane-bound, but a soluble form of PD-L1 (sPD-L1) also exists and high serum levels of sPD-L1 are associated with poor prognosis in renal-cell carcinoma and multiple myeloma (27, 28). Here, SPDL1 is linked to renal cell carcinoma.